Results 231 to 240 of about 4,544,497 (292)

Comparative Cardiovascular Outcomes in Acalabrutinib vs. Zanubrutinib in B-Cell Malignancies: A TriNetX Data Study. [PDF]

Curr Oncol
Awad M, Tah S, Ahmad S, Patel H, Kumsi Sreedhar P, Lingamsetty SSP, Murshid A, Patel B.   +7 more
europepmc   +1 more source

Guillain‐Barré Syndrome in Late Pregnancy Following Respiratory Syncytial Virus Infection: A Diagnostic Dilemma

Clinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT The diagnosis of Guillain–Barré syndrome (GBS) relies on evolving clinical features, supported by cerebrospinal fluid (CSF), laboratory investigations, and electrodiagnostic studies. Early investigations may be nondiagnostic and should not delay treatment when progressive neurological deterioration raises clinical suspicion of GBS.
Rhiana Pereira‐Lindley, Mesharck Gariba, Darshan Lal   +2 more
wiley   +1 more source

DENND3-p.R534S disrupts dyadic microdomain architecture to drive potentially pro-arrhythmic calcium and electrophysiologic instability. [PDF]

Europace
Gao S, Kim CJ, Ye D, Tester DJ, Giudicessi JR, Ackerman MJ.   +5 more
europepmc   +1 more source

In Silico Clinical Trials in Drug Development: Virtual Patients, Applications, and Regulatory Convergence

Clinical Pharmacology &Therapeutics, Volume 120, Issue 5, Page 1181-1194, November 2026.
Conventional clinical trials remain the benchmark for evaluating therapeutic safety and efficacy, yet they are constrained by escalating costs, withdrawal over the extended follow‐up periods, recruitment difficulties, ethical limits, and a restricted ability to characterize heterogeneous populations.
Maximilian Balmus, Sheng‐Ya Wang, Edward W. G. Ashton, Rosie K. Barrows, Molly Monks, Yuzhang Ge, Arthur Lefebvre, Steven A. Niederer   +7 more
wiley   +1 more source

An integrated multi-omics study of key mediators and therapeutic targets for doxorubicin-induced atrial fibrillation. [PDF]

PLoS One
Li Z, Liu S, He J, Wang T, Ma J.
europepmc   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

Head &Neck, Volume 48, Issue 11, Page 3152-3172, November 2026.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell, E. C. Ward, L. R. Wishart, R. Perera, C. Barrett, K. A. Edmiston, E. Mitchell, A. Pigott, R. Pitt, K. Russell, B. A. Chan, R. Ladwa   +11 more
wiley   +1 more source

IL-18 in atherosclerosis: context-dependent biology, human evidence, and translational challenges. [PDF]

Front Cardiovasc Med
Zhang D, Wang S, Li Y, Zhang H, Wang B.
europepmc   +1 more source

Comparative Effects of Photobiomodulation and Platelet‐Rich Plasma on Joint Repair in Rats With Knee Osteoarthritis

Lasers in Surgery and Medicine, Volume 58, Issue 9, Page 802-810, November 2026.
ABSTRACT Objective This study aimed to evaluate whether the combination of photobiomodulation and platelet‐rich plasma therapy provides superior anti‐inflammatory and joint‐protective effects compared to individual treatments in an experimental model of osteoarthritis.
Anne Missrie, Gabriela Saab Sampaio, Vitória Gonzaga Acerbi, Fernando Anselmo, Ítalo Ribeiro Lemes, Ana Laura Martins de Andrade   +5 more
wiley   +1 more source